These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1176 related articles for article (PubMed ID: 33704002)
1. Role of ACE2 genetic polymorphisms in susceptibility to SARS-CoV-2 among highly exposed but non infected healthcare workers. Martínez-Sanz J; Jiménez D; Martínez-Campelo L; Cruz R; Vizcarra P; Sánchez-Conde M; Ron R; Rodríguez M; Herrera S; Moreno S; López-Huertas MR; Serrano-Villar S Emerg Microbes Infect; 2021 Dec; 10(1):493-496. PubMed ID: 33704002 [TBL] [Abstract][Full Text] [Related]
2. Polymorphisms and mutations of ACE2 and TMPRSS2 genes are associated with COVID-19: a systematic review. Li J; Wang Y; Liu Y; Zhang Z; Zhai Y; Dai Y; Wu Z; Nie X; Du L Eur J Med Res; 2022 Feb; 27(1):26. PubMed ID: 35193695 [TBL] [Abstract][Full Text] [Related]
3. ACE2 polymorphism and susceptibility for SARS-CoV-2 infection and severity of COVID-19. Möhlendick B; Schönfelder K; Breuckmann K; Elsner C; Babel N; Balfanz P; Dahl E; Dreher M; Fistera D; Herbstreit F; Hölzer B; Koch M; Kohnle M; Marx N; Risse J; Schmidt K; Skrzypczyk S; Sutharsan S; Taube C; Westhoff TH; Jöckel KH; Dittmer U; Siffert W; Kribben A Pharmacogenet Genomics; 2021 Oct; 31(8):165-171. PubMed ID: 34001841 [TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in ACE, ACE2, AGTR1 genes and severity of COVID-19 disease. Sabater Molina M; Nicolás Rocamora E; Bendicho AI; Vázquez EG; Zorio E; Rodriguez FD; Gil Ortuño C; Rodríguez AI; Sánchez-López AJ; Jara Rubio R; Moreno-Docón A; Marcos PJ; García Pavía P; Villa RB; Gimeno Blanes JR PLoS One; 2022; 17(2):e0263140. PubMed ID: 35120165 [TBL] [Abstract][Full Text] [Related]
5. Population-Specific Hashizume M; Gonzalez G; Ono C; Takashima A; Iwasaki M Viruses; 2021 Jan; 13(1):. PubMed ID: 33418950 [TBL] [Abstract][Full Text] [Related]
6. Association of ACE2 Gene Variants with the Severity of COVID-19 Disease-A Prospective Observational Study. Sienko J; Marczak I; Kotowski M; Bogacz A; Tejchman K; Sienko M; Kotfis K Int J Environ Res Public Health; 2022 Oct; 19(19):. PubMed ID: 36231922 [TBL] [Abstract][Full Text] [Related]
8. Assessing COVID-19 susceptibility through analysis of the genetic and epigenetic diversity of ACE2-mediated SARS-CoV-2 entry. Ragia G; Manolopoulos VG Pharmacogenomics; 2020 Dec; 21(18):1311-1329. PubMed ID: 33243086 [TBL] [Abstract][Full Text] [Related]
9. Impact of Genetic Variability in ACE2 Expression on the Evolutionary Dynamics of SARS-CoV-2 Spike D614G Mutation. Huang SW; Miller SO; Yen CH; Wang SF Genes (Basel); 2020 Dec; 12(1):. PubMed ID: 33374416 [TBL] [Abstract][Full Text] [Related]
10. ACE2: from protection of liver disease to propagation of COVID-19. Warner FJ; Rajapaksha H; Shackel N; Herath CB Clin Sci (Lond); 2020 Dec; 134(23):3137-3158. PubMed ID: 33284956 [TBL] [Abstract][Full Text] [Related]
11. Investigation of the genetic variation in ACE2 on the structural recognition by the novel coronavirus (SARS-CoV-2). Guo X; Chen Z; Xia Y; Lin W; Li H J Transl Med; 2020 Aug; 18(1):321. PubMed ID: 32831104 [TBL] [Abstract][Full Text] [Related]
12. TYK2 single-nucleotide variants associated with the severity of COVID-19 disease. Zabihi Rizi F; Ghorbani A; Zahtab P; Darbaghshahi NN; Ataee N; Pourhamzeh P; Hamzei B; Dolatabadi NF; Zamani A; Hooshmand M Arch Virol; 2023 Mar; 168(4):119. PubMed ID: 36959416 [TBL] [Abstract][Full Text] [Related]
13. Strong Correlation between the Case Fatality Rate of COVID-19 and the rs6598045 Single Nucleotide Polymorphism (SNP) of the Interferon-Induced Transmembrane Protein 3 ( Kim YC; Jeong BH Genes (Basel); 2020 Dec; 12(1):. PubMed ID: 33396837 [TBL] [Abstract][Full Text] [Related]
14. Predictive Factors and Varillas-Delgado D; Jimenez-Antona C; Lizcano-Alvarez A; Cano-de-la-Cuerda R; Molero-Sanchez A; Laguarta-Val S Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069039 [TBL] [Abstract][Full Text] [Related]
15. Saih A; Baba H; Bouqdayr M; Ghazal H; Hamdi S; Kettani A; Wakrim L Biomed Res Int; 2021; 2021():6685840. PubMed ID: 33884270 [TBL] [Abstract][Full Text] [Related]
17. Investigating the ACE2 polymorphisms in COVID-19 susceptibility: An in silico analysis. Pouladi N; Abdolahi S Mol Genet Genomic Med; 2021 Jun; 9(6):e1672. PubMed ID: 33818000 [TBL] [Abstract][Full Text] [Related]
18. Implications of the Immune Polymorphisms of the Host and the Genetic Variability of SARS-CoV-2 in the Development of COVID-19. Zepeda-Cervantes J; Martínez-Flores D; Ramírez-Jarquín JO; Tecalco-Cruz ÁC; Alavez-Pérez NS; Vaca L; Sarmiento-Silva RE Viruses; 2022 Jan; 14(1):. PubMed ID: 35062298 [TBL] [Abstract][Full Text] [Related]
19. Angiotensin-converting enzyme 2 (ACE2) polymorphisms and susceptibility of severe SARS-CoV-2 in a subset of Pakistani population. Sidhwani SK; Mirza T; Khatoon A; Shaikh F; Khan R; Shaikh OA; Nashwan AJ Virol J; 2023 Jun; 20(1):120. PubMed ID: 37308887 [TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 Receptor ACE2 Gene Is Associated with Hypertension and Severity of COVID 19: Interaction with Sex, Obesity, and Smoking. Hamet P; Pausova Z; Attaoua R; Hishmih C; Haloui M; Shin J; Paus T; Abrahamowicz M; Gaudet D; Santucci L; Kotchen TA; Cowley AW; Hussin J; Tremblay J Am J Hypertens; 2021 Apr; 34(4):367-376. PubMed ID: 33386398 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]